PhaseBio Pharmaceuticals Inc. (PHAS) Reports Publication of Full Results from Phase 1 Clinical Trial of PB2452
Menarini Group, Radius Health Announce License Agreement for Elacestrant
– Menarini licenses global development and commercialization rights of elacestrant, an oral SERD currently in late stage Phase 3 development – Elacestrant further strengthens Menarini’s global oncology portfolio, recently bolstered by the acquisition of Stemline…
Duke Signed a License Agreement with Splendo Health
Duke University and Splendo Health have entered into a license agreement. The Dutch digital health startup is a collaboration between Duke University and Splendo Consulting. Splendo Health has developed SplendoFit, a comprehensive digital platform with…
Aerie Concludes Exclusive License Agreement With Santen for Rhopressa® and Rocklatan® in Europe and Several Other Regions
Agreement includes Europe, Commonwealth of Independent States countries, China, India, parts of Latin America and the Oceania countries DURHAM, N.C.–(BUSINESS WIRE), December 7, 2021–Aerie Pharmaceuticals, Inc. (NASDAQ: AERI, “Aerie”) announced that Aerie and Santen have…
Duke-linked crop science startup Avalo raises $500K, looks for another $600K
DURHAM – Avalo, a Durham-based startup with ties to Duke University, has raised an additional $500,000 from two investors, according to an SEC filing. The company describes itself as “generating crop resilience through gene discovery for a…
Medical Innovation Challenge
Join the world’s largest medical innovation accelerator program and $50K prize program! Align with leading medtech consortia representing over $20 billion in health technology contracting authority. This challenge is the first in a series of…